Oral mucosal diseases: Mucous membrane pemphigoid

被引:50
作者
Scully, Crispian [1 ]
Lo Muzio, Lorenzo [2 ]
机构
[1] UCL, Eastman Dent Inst, London WC1X 8LD, England
[2] Univ Foggia, Dept Surg Sci, Foggia, Italy
关键词
pemphigoid; skin autoimmune; corticosteroids; immunosuppressants; oral;
D O I
10.1016/j.bjoms.2007.07.200
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Subepithelial vesiculobullous conditions are chronic autoimmune disorders that arise from reactions directed against components of the hemidesmosomes or basement membrane zones (BMZ) of stratified squamous epithelium to which the term immune-mediated subepithelial blistering diseases (IMSEBD) has been given. Mucous membrane pemphigoid (MMP) is the most common, but variants do exist. Non-immune disorders that involve these epithelial components typically have a genetic basis-the main example being epidermolysis bullosa. All subepithelial vesiculobullous disorders present as blisters and erosions, and diagnosis must be confirmed by biopsy examination with immunostaining, sometimes supplemented by other investigations. No single treatment reliably controls all subepithelial vesiculobullous disorders; the immunological differences within IMSEBD may account for differences in responses to treatment. Currently, as well as improving oral hygiene, immunomodulatory treatment is used to control the oral lesions of MMP, but it is not known if its specific subsets reliably respond to different agents. (C) 2007 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:358 / 366
页数:9
相关论文
共 162 条
[1]   CYCLOPHOSPHAMIDE (CYTOXAN) - A REVIEW ON RELEVANT PHARMACOLOGY AND CLINICAL USES [J].
AHMED, AR ;
HOMBAL, SM .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1984, 11 (06) :1115-1126
[2]   AZATHIOPRINE [J].
AHMED, AR ;
MOY, R .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1981, 20 (07) :461-467
[3]   CICATRICIAL PEMPHIGOID [J].
AHMED, AR ;
HOMBAL, SM .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1986, 25 (02) :90-96
[4]  
Ahmed AR, 2001, ARCH DERMATOL, V137, P1181
[5]   CICATRICIAL PEMPHIGOID [J].
AHMED, AR ;
KURGIS, BS ;
ROGERS, RS .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1991, 24 (06) :987-1001
[6]   ASSOCIATION OF DQW7 (DQB1-STAR-0301) WITH OCULAR CICATRICIAL PEMPHIGOID [J].
AHMED, AR ;
FOSTER, S ;
ZALTAS, M ;
NOTANI, G ;
AWDEH, Z ;
ALPER, CA ;
YUNIS, EJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (24) :11579-11582
[7]   A clinical study of oral mucous membrane pemphigoid [J].
Alkan, A ;
Günhan, Ö ;
Alkan, A ;
Otan, F .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2003, 31 (04) :340-344
[8]  
ANHALT GJ, 1990, DERMATOL CLIN, V8, P701
[9]   Subepidermal autoimmune bullous skin diseases associated with B-cell lymphoproliferative disorders [J].
Aractingi, S ;
Bachmeyer, C ;
Prost, C ;
Caux, F ;
Flageul, B ;
Fermand, JP .
MEDICINE, 1999, 78 (04) :228-235
[10]   Topical tacrolimus for oral cicatricial pemphigoid [J].
Assmann, T ;
Becker, J ;
Ruzicka, T ;
Megahed, M .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2004, 29 (06) :674-676